PON1 and coronary artery disorder: Therefore, studies are needed to determine the specific lysine residues of PON1 modified by IsoLG when added in vitro, the effect of these modification on PON1 structure, and whether these same modifications are increased for PON1 isolated from individuals with coronary artery disease.